Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $34.1600 (0.69%) ($32.7900 - $34.2250) on Thu. Jun. 15, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.24% (three month average) | RSI | 56 | Latest Price | $34.1600(0.69%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.4% a day on average for past five trading days. | Weekly Trend | HALO advances 1.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IFRA(35%) IWO(31%) IWM(30%) SDY(30%) IWN(29%) | Factors Impacting HALO price | HALO will decline at least -1.62% in a week (0% probabilities). UUP(-17%) TBT(-16%) EDOC(-12%) IGOV(-11%) ARKK(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.62% (StdDev 3.24%) | Hourly BBV | 0 () | Intraday Trend | 3.7% | | | |
|
5 Day Moving Average | $34.01(0.44%) | 10 Day Moving Average | $33.83(0.98%) | 20 Day Moving Average | $33.67(1.46%) | To recent high | -14.7% | To recent low | 13.3% | Market Cap | $4.669b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |